BACKGROUND: The Childhood Asthma Control Test (C-ACT) has been proposed as a tool in assessing the level of disease control in asthmatic children. To evaluate the position of C-ACT in the clinical management of asthmatic children, in relationship to the level of airway inflammation as assessed by fractional exhaled nitric oxide (FeNO) and with lung function. METHODS: A total of 200 asthmatic children were included in the study: 47 children with newly diagnosed asthma ('New') and without any regular controller therapy; and 153 children with previously diagnosed asthma, treated according to GINA guidelines, and evaluated during a scheduled follow-up visit ('Follow-up'). Childhood Asthma Control Test, FeNO and lung function [forced expiratory volume 1 (FEV1) and forced vital capacity (FVC)] were evaluated. RESULTS: In New vs Follow-up participants, C-ACT score (P < 0.001), FVC (P < 0.005) and FEV1 (P < 0.05) were significantly lower, and FeNO (P = 0.011) were significantly higher. In New, but not in Follow-up participants, significant correlations were observed between C-ACT score and FeNO (r = -0.51; P < 0.001), FEV1 (r = 0.34; P = 0.022) and FEV1/FVC (r = 0.32; P = 0.03). This lack of correlation in Follow-up visits seemed attributable to dissociation between inadequately controlled asthma by C-ACT ratings with normalization of other measures such as FeNO levels. CONCLUSIONS: This study confirms and expands the concept that C-ACT is complementary to, but not a substitute for, other markers of disease control in asthmatic children, especially in the context of follow-up visits.
BACKGROUND: The Childhood Asthma Control Test (C-ACT) has been proposed as a tool in assessing the level of disease control in asthmatic children. To evaluate the position of C-ACT in the clinical management of asthmatic children, in relationship to the level of airway inflammation as assessed by fractional exhaled nitric oxide (FeNO) and with lung function. METHODS: A total of 200 asthmatic children were included in the study: 47 children with newly diagnosed asthma ('New') and without any regular controller therapy; and 153 children with previously diagnosed asthma, treated according to GINA guidelines, and evaluated during a scheduled follow-up visit ('Follow-up'). Childhood Asthma Control Test, FeNO and lung function [forced expiratory volume 1 (FEV1) and forced vital capacity (FVC)] were evaluated. RESULTS: In New vs Follow-up participants, C-ACT score (P < 0.001), FVC (P < 0.005) and FEV1 (P < 0.05) were significantly lower, and FeNO (P = 0.011) were significantly higher. In New, but not in Follow-up participants, significant correlations were observed between C-ACT score and FeNO (r = -0.51; P < 0.001), FEV1 (r = 0.34; P = 0.022) and FEV1/FVC (r = 0.32; P = 0.03). This lack of correlation in Follow-up visits seemed attributable to dissociation between inadequately controlled asthma by C-ACT ratings with normalization of other measures such as FeNO levels. CONCLUSIONS: This study confirms and expands the concept that C-ACT is complementary to, but not a substitute for, other markers of disease control in asthmatic children, especially in the context of follow-up visits.
Authors: B E Sekerel; O U Soyer; O Keskin; N Uzuner; M Yazicioglu; M Kiliç; H Artaç; S Ozmen; D Can; D Zeyrek; H Cokugras; Y Canitez; M Aydogan; S Kuyucu; A Inal; F Gurkan; F Orhan; O Yilmaz; A B Boz; F Tahan; O Cevit Journal: Qual Life Res Date: 2011-07-27 Impact factor: 4.147
Authors: Yixin Shi; Ahramahzd V Tatavoosian; Anna S Aledia; Steven C George; Stanley P Galant Journal: Ann Allergy Asthma Immunol Date: 2012-07-04 Impact factor: 6.347
Authors: Marina Attanasi; Nicola P Consilvio; Daniele Rapino; Marta Di Nicola; Alessandra Scaparrotta; Anna Cingolani; Marianna I Petrosino; Paola Di Filippo; Sabrina Di Pillo; Francesco Chiarelli Journal: Arch Med Sci Date: 2016-02-02 Impact factor: 3.318
Authors: Amelia Licari; Ilaria Brambilla; Alessia Marseglia; Maria De Filippo; Valeria Paganelli; Gian L Marseglia Journal: Front Pediatr Date: 2018-06-19 Impact factor: 3.418
Authors: Anna Bednarek; Anna Bodajko-Grochowska; Małgorzata Bartkowiak-Emeryk; Robert Klepacz; Janusz Ciółkowski; Danuta Zarzycka; Andrzej Emeryk Journal: Postepy Dermatol Alergol Date: 2018-06-18 Impact factor: 1.837
Authors: S Turner; S C Cotton; C D Emele; R Thomas; S Fielding; E A Gaillard; J C de Jongste; H Morgan; A R Neilson; J Norrie; M Pijnenburg; D Price; M Thomas Journal: Trials Date: 2019-10-04 Impact factor: 2.279